Mednet Logo
HomeDermatology
Dermatology

Dermatology

Clinical insights on skin conditions, dermatologic procedures, and treatment approaches from practicing dermatologists.

Recent Discussions

What procedures do you recommend for patients interested in xanthelasma removal?

3
3 Answers

Mednet Member
Mednet Member
Dermatology · Central Dermatology Center

I have had success treating xanthelasma with both hyfrecation (particularly for very small lesions) and fully ablative laser (both CO2 and Erb-YAG).

What’s your favorite topical OTC moisturizer that you recommend, and why?

2 Answers

Mednet Member
Mednet Member
Dermatology · University of California San Francisco Medical School

There is no easy answer to this question as recommendations for moisturizers are quite patient and location specific and depend on degrees of dryness. The best moisturizer is one that feels good to the individual patient and is one that he/she will then use. For example, someone with mild facial dry...

What topical regimens do you recommend for redness related to rosacea in patients who defer laser treatments?

2
1 Answers

Mednet Member
Mednet Member
Dermatology · UCLA

Naturally, laser is the most ideal and best solution. Green-tinted makeup is also a great adjunct. Aside from the usual routine counseling (avoidance of sun, food triggers, etc.), one product that I have found remarkable results with is the compounded SkinMedicinals ET-Rosacea Cream, which contains ...

Do you anticipate trying nemolizumab in patients with other difficult to treat pruritic conditions?

2 Answers

Mednet Member
Mednet Member
Dermatology · UCONN

I have already used this drug in a multitude of off-label indications, including but not limited to lichen simplex chronicus, acne keloidalis nuchae, keloids secondary to acne fulminans, delusions of parasitosis, itch of unknown origin, nostalgia parasitic, scrotal pruritus, and occipital neuralgia.

What therapies have you found most effective for managing patients with Darier disease?

1
3 Answers

Mednet Member
Mednet Member
Dermatology · Duke Health

Because of the amazing bench-to-bedside paper below, my most severe Darier's patient started on an IL17 inhibitor, and it is the closest thing I've seen to a miracle in ages. She was refractory to everything we tried, and is now 80+% clear. What a joy to see science change people's lives!Ettinger et...

What incubation times do you use for PDT?

1
3 Answers

Mednet Member
Mednet Member
Dermatology · Baylor College of Medicine

We have had good success with the zero incubation time + 2 back-to-back illumination cycles method described by Gandy et al. This method involves no pain and an overall shorter visit time compared to standard incubation protocols.Briefly, this method includes the following steps: Prep treatment area...

What is your approach to a patient with generalized morphea, no systemic involvement but a positive RNA Polymerase III?

3 Answers

Mednet Member
Mednet Member
Rheumatology · Yale School of Medicine

I would perform age-appropriate cancer screening given the link between RNA pol III and cancer. Otherwise, I would simply monitor for onset of systemic sclerosis or other autoimmune disease symptoms.

Among the metastatic/unresectable melanoma patients you would historically treat with anti-PD-1 monotherapy, are you now recommending nivolumab/relatlimab instead?

1
2 Answers

Mednet Member
Mednet Member
Medical Oncology · The Ohio State University Comprehensive Cancer Center / James Cancer Hospital and Solove Research Institute

Based on the published RELATIVITY-047 study, the nivo/rela combination leads to a superior median PFS of 10.2 mo (vs 4.6 mo for nivo alone) - both updated at ASCO 2022. At the most recent update at the ASCO 2022, the median survival has not been reached yet for the patients treated with nivo/rela (v...

Would you recommend sentinel lymph node biopsy at the time of wide excision for a 3 mm Merkel cell carcinoma of the cheek/lateral canthus?

2
3 Answers

Mednet Member
Mednet Member
Dermatology · Florida State University College of Medicine

Unlike melanoma and certainly NMSC, MCC is highly unpredictable in nature, with clinical lesion size having little clinical prognostic value. As such, it appears that SLNB is valuable in many cases for the purposes of prognosis and in determining the need for adjuvant systemic therapy and radiation....

Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?

10
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Michigan

I would recommend both an MRI as well as consulting the pathologist regarding the exact nature of the PNI. We had an experience with more than 100 patients (Sapir et al., PMID 27475277). Those with gross PNI (evidenced by MRI, with or without cranial nerve deficit) and microscopic extensive PNI (>2 ...